IRCT20220212054005N1 IRCT 2023-02-18 Shiraz University of Medical Sciences clinical clinical trail The radioprotective effect of oral nanocurcumin in thyroid cancer patients after high dose radioactive iodine administration by examining the amount of inflamatory factor TNFα by ELISA test in patients blood serum 2022-07-01 anticipated 44 Complete https://irct.ir/trial/61920 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Used, Assignment: Parallel, Purpose: Treatment, Randomization description: Randomization is done in a simple way, so that one of the study groups are considered to be lions and the other group to be lines, and based on the desired sample size, the same number A coin is tossed and people are randomly assigned to two groups, Blinding description: The study is one-way blinded and the study participants are blinded to the intervention in such a way that the placebo is prepared from drug-colored capsules containing a little starch and the patients do not know whether they are receiving the drug or the placebo. 3 Thyroid cancer. Intervention group: Considering that our goal is to be able to use the results of the study to improve the harmful effects caused by radiation in the treatment of patients, therefore, the nanomicelle curcumin sample of Erin Salamat Sina Company approved by the Ministry of Health as a dietary supplement with a dose of 40 mg of nano curcumin that is consumed These capsules are allowed to be taken one per day. Therefore, in order to conduct this study, one capsule per day will be prescribed according to the standard drug protocol three days before and seven days after the treatment.. No - There is not a plan to make this available Justification or reason for not sharing IPD is There is no further information.